Projects

Find all JCSMR research projects.

Projects Open to Honours for Semester 1 2022

Projects Open to Honours for Semester 1 2022 »

Learn about the Honours projects available at JCSMR.

Group

Projects	Groups	Status
MicroRNA as diagnostics and therapeutics for retinal degenerations	The Natoli Group - Clear Vision Research Lab	Current
The benefits of exercise for retinal health and reducing retinal degenerations	The Natoli Group - Clear Vision Research Lab	Current
670nm Red Light as a treatment for Retinopathy of Prematurity (Phase 1 Clinical Trial)	The Valter Group - Retinal Cell Damage and Repair	Current
A longitudinal study of depression, anxiety, substance use and cognitive change: PATH Through Life		Current
A novel mechanism of epigenetic information transfer between different cell types	The Soboleva Group - Germ Cell and Cancer Epigenetics	Potential
A novel role for the pol I transcription factor UBF in the regulation of expression of histone gene clusters and cellular DNA damage responses	The Hannan Group - Cancer Therapeutics	Current
Antibacterial biomaterials for future orthopaedic implants	The Li Group - Trauma and Orthopaedic Research Unit	Potential
B cell responses to malaria	The Cockburn Group - Malaria Immunology	Potential
Brain tumour models	The Quinn Group - Cancer Models	Current
Calcium imaging of presynaptic terminals		Current
Cancer Stem Cell Models	The Quinn Group - Cancer Models	Current
Characterisation of the role of H2A.B spermatogenesis during heat stress	The Soboleva Group - Germ Cell and Cancer Epigenetics	Potential
Characterising 3D image structure	The Maddess Group - Diagnostics for Eye Diseases	Potential
Characterising the function of general transcription elongation factor Paf1 complex in transposon defence	The Hayashi Group - Transposon defence and animal development	Current
Chromatin and RNA surveillance	The Fischer Group - Epigenetics and Genomic Stability	Current
Circuit mapping in the piriform cortex using optogenetics	The Bekkers Group - Olfaction	Current
Click chemistry enables evaluation of the molecular mechanism of the 2nd generation RNA polymerase I inhibitor, PMR-116	The Hannan Group - Cancer Therapeutics	Current
Consequences of impaired neuronal activity during development in a mouse model of autism	The Dehorter Group - Neuronal Development	Potential
Determining synaptic properties in small networks of neurons		Current
Development of a molecular tool for personalised cancer treatment – a synthetic biology approach	The Fischer Group - Epigenetics and Genomic Stability	Current
Development of CRISPR/Cas9 genome editing technology	The Burgio Group - Genome editing	Potential
Development of new animal models for retinal degenerations	The Natoli Group - Clear Vision Research Lab	Current
Development of novel drugs for the treatment of sepsis	The Parish Group - Cancer & Vascular Biology	Current
Discovery of novel cis-regulatory RNA structures using deep neural network	The Wen Group - Computational Biology of RNAs and Functional Genomics	Current
Embryonic development: How does elevated Wnt signalling cause heart defects?	The Arkell Group - Early Mammalian Development	Potential